[1]
“Treatment Retention and Hemoglobin Response During Darbepoetin Alfa and Recombinant Human Erythropoietin Beta Therapy in Children With CKD-Related Anemia: A Secondary Analysis of a Randomized Trial”, Planet (Barisal), vol. 10, no. 03, pp. 1103–1106, Nov. 2026, doi: 10.5281/zenodo.23912066.